Clinical Durability of Hyaluronic Acid-Based Dermal Fillers for Facial Application: A Systematic Review.
Abstract
[BACKGROUND] Hyaluronic acid (HA) fillers are widely regarded as safe and effective for soft tissue augmentation, including correction of nasolabial folds, wrinkles, lips, and facial contouring. Despite favorable clinical outcomes, long-term durability remains under investigation.
[OBJECTIVE] To systematically review the effects of facial HA fillers on durability, patient satisfaction, and adverse events, providing a comprehensive overview for clinical and aesthetic practice.
[METHODS] A systematic search was conducted in Virtual Health Library (BVS), Embase, PubMed, Web of Science, and Scopus for clinical and observational studies, case reports, and series reporting quantitative data with ≥12 months follow-up. Studies included patients treated with various HA formulations and focused on filler longevity, subjective satisfaction, and adverse effects.
[RESULTS] Twenty-four studies from 13 countries including 1,410 patients (81.8% female, 21-76 years) were analyzed. Nineteen HA brands were reported, with Restylane most frequent (21.1%). 3D volumetric assessments (64%) showed HA persistence of 50-86% at 24 months and 60-86.4% at 12 months, with one study reporting 6-9 months. Ultrasound (20%) indicated 12-36 months persistence; MRI (8%) and profilometry (4%) reported presence up to 12 months. Patient-reported satisfaction, measured via subjective scales, aligned with objective findings, declining alongside quantitative HA volume over time. Adverse effects were evaluated, with the majority immediate (72.6%) and long-term events rare (4.8%).
[CONCLUSION] HA filler longevity is influenced by manufacturing technology, tissue mobility, and anatomical factors. All technologies demonstrated good durability, though Vycross was associated with more long-term adverse events. Subjective satisfaction mirrored objective persistence, emphasizing the clinical relevance of both assessments. Individualized product selection remains essential to achieve safe, predictable, and satisfactory outcomes.
[LEVEL OF EVIDENCE I] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
[OBJECTIVE] To systematically review the effects of facial HA fillers on durability, patient satisfaction, and adverse events, providing a comprehensive overview for clinical and aesthetic practice.
[METHODS] A systematic search was conducted in Virtual Health Library (BVS), Embase, PubMed, Web of Science, and Scopus for clinical and observational studies, case reports, and series reporting quantitative data with ≥12 months follow-up. Studies included patients treated with various HA formulations and focused on filler longevity, subjective satisfaction, and adverse effects.
[RESULTS] Twenty-four studies from 13 countries including 1,410 patients (81.8% female, 21-76 years) were analyzed. Nineteen HA brands were reported, with Restylane most frequent (21.1%). 3D volumetric assessments (64%) showed HA persistence of 50-86% at 24 months and 60-86.4% at 12 months, with one study reporting 6-9 months. Ultrasound (20%) indicated 12-36 months persistence; MRI (8%) and profilometry (4%) reported presence up to 12 months. Patient-reported satisfaction, measured via subjective scales, aligned with objective findings, declining alongside quantitative HA volume over time. Adverse effects were evaluated, with the majority immediate (72.6%) and long-term events rare (4.8%).
[CONCLUSION] HA filler longevity is influenced by manufacturing technology, tissue mobility, and anatomical factors. All technologies demonstrated good durability, though Vycross was associated with more long-term adverse events. Subjective satisfaction mirrored objective persistence, emphasizing the clinical relevance of both assessments. Individualized product selection remains essential to achieve safe, predictable, and satisfactory outcomes.
[LEVEL OF EVIDENCE I] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | ha
|
히알루론산 | dict | 7 | |
| 재료 | hyaluronic acid
|
히알루론산 | dict | 2 | |
| 시술 | filler
|
필러 주입술 | dict | 1 | |
| 시술 | ha filler
|
필러 주입술 | dict | 1 | |
| 시술 | facial contouring
|
안면윤곽술 | dict | 1 |
MeSH Terms
Humans; Dermal Fillers; Hyaluronic Acid; Skin Aging; Patient Satisfaction; Cosmetic Techniques; Female; Treatment Outcome; Esthetics; Face; Adult; Male; Middle Aged; Rejuvenation; Risk Assessment; Aged; Young Adult
📑 인용 관계
이 논문이 참조한 문헌 43
- Etiology of Delayed Inflammatory Reaction Induced by Hyaluronic Acid Filler.
- Restoring long-lasting midface volume in the Asian face with a hyaluronic acid filler: A randomized …
- Hyaluronic Acid Filler VYC-25L for Jawline Restoration Yields High Satisfaction, Improved Jawline Me…
- Manufacturing Process of Hyaluronic Acid Dermal Fillers.
- A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid-bas…
- Investigation of Crosslinking Parameters and Characterization of Hyaluronic Acid Dermal Fillers: Fro…
- Efficacy and safety of hyaluronic acid fillers for lip augmentation in a Chinese population.
- Nonsurgical Rhinoplasty: Long-Term Follow-Up of High G' HA Nasal Injections.
- Current Practices in Hyaluronic Acid Dermal Filler Treatment in Asia Pacific and Practical Approache…
- Lifting the midface using a hyaluronic acid filler with lidocaine: A randomized multi-center study i…
- Elucidations on the Performance and Reversibility of Treatment with Hyaluronic Acid Based Dermal Fil…
- In vitro toxicity assessment of crosslinking agents used in hyaluronic acid dermal filler.
- Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/…
- Ex vivo magnetic resonance imaging using hyaluronic acid fillers: Differences between monophasic and…
- Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre-clini…
- Cohesive Polydensified Matrix hyaluronic acid volumizer injected for cheek augmentation has addition…
- Basics of dermal filler rheology.
- Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and M…
- High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restorat…
- A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hya…
외부 PMID 23건 (DB 미수집)
- PMID 19712480 ↗
- PMID 20440170 ↗
- PMID 20653347 ↗
- PMID 21272119 ↗
- PMID 23044151 ↗
- PMID 24299766 ↗
- PMID 27168268 ↗
- PMID 27923810 ↗
- PMID 29420178 ↗
- PMID 30350909 ↗
- PMID 31135570 ↗
- PMID 33789826 ↗
- PMID 34295171 ↗
- PMID 34536051 ↗
- PMID 34882503 ↗
- PMID 35114708 ↗
- PMID 35511071 ↗
- PMID 36142430 ↗
- PMID 36730370 ↗
- PMID 37095274 ↗
- PMID 37700793 ↗
- PMID 37752833 ↗
- PMID 38954752 ↗
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- Long-term effects of inferior alveolar nerve injury on the quality of life of orthognathic patients: a clinical assessment.